SUNZEN BIOTECH BHD
KLSE (MYR): SUNZEN (0148)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.34
Today's Change
0.00 (0.00%)
Day's Change
0.335 - 0.34
Trading Volume
488,000
Overview
Market Cap
250 Million
NOSH
734 Million
Avg Volume (4 weeks)
812,205
4 Weeks Range
0.31 - 0.345
4 Weeks Price Volatility (%)
85.71%
52 Weeks Range
0.20 - 0.40
52 Weeks Price Volatility (%)
70.00%
Previous Close
0.34
Open
0.34
Bid
0.335 x 346,200
Ask
0.34 x 118,400
Day's Range
0.335 - 0.34
Trading Volume
488,000
Financial Highlight
Latest Quarter | Ann. Date
30-Jun-2024 | 29-Aug-2024
Next QR | Est. Ann. Date
30-Sep-2024 | 29-Nov-2024
T4Q P/E | EY
34.79 | 2.87%
T4Q DY | Payout %
0.00% | 0.00%
T4Q NAPS | P/NAPS
0.19 | 1.77
T4Q NP Margin | ROE
8.16% | 5.08%
Market Buzz
2024-09-30
2024-09-23
2024-09-23
News and Blogs
Related videos
Company Profile
Sector: CONSUMER PRODUCTS & SERVICES
Sector: CONSUMER PRODUCTS & SERVICES
Subsector: AGRICULTURAL PRODUCTS
Subsector: AGRICULTURAL PRODUCTS
Description:
Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates through two divisions. The Manufacturing division is involved in the manufacturing and marketing of animal health products such as orgacids, zenacids, om, pfactor, and pfi-lyte. In addition, it also produces palm oil products such as powder fats for livestock animals. The Trading division includes the distribution and marketing of veterinary pharmaceuticals and animal vaccines, and detergent and disinfectant products such as shift, lindores and gpc 8.
Discussions
5 people like this. Showing 50 of 2,203 comments
The business covers Chinese medicine, herbal health food and beverages, bird's nest and loan financing. Still considered diversified
2 months ago
she have last 10 millions shares to sell, only than no more road blocks to challenge 0.45.
2 months ago
Truly one of the hidden gem, Sunzen performance are improving alot after acquiring YANMING、FINSOURCE & ECOLITE
1 month ago
They always work together to create, innovate, and produce the best quality health products for the better living of the community
1 month ago
caught some at 0.31... cheap & nice to hold... if this week can climb back like you say then nice lor..
1 month ago
next qr should see some improvement with the positive growth of biotech industry
1 month ago
0.31-0.32 is a steady & cheap entry price now, Sunzen entering the healthcare sector will push the price further up
1 month ago
Strong growth every quarter, Sunzen future prospect is really bright with new acquisition
1 month ago
Next quarter's revenue and net profit will both increase quarter-on-quarter and year-on-year, I believe
1 month ago
Sunzen has decreased current liabilities to 6.3% of total assets over this period. Good sign
1 month ago
I just watched it. Must say the new management seems to be doing the right thing compare to the previous one. At least now SUNZEN is no longer losing money but making profit
1 week ago
Hopes the Xmegami lenglui will buy in sunzen also since their earning so high every month
16 hours ago
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
.png)
MQ Trading Signals
Time
Signal
Duration
Type
2024-09-30 14:30:00
EMA 5
30 Mins
BUY
2024-09-30 14:00:00
EMA 5
10 Mins
BUY
2024-09-30 12:30:00
EMA 5
10 Mins
BUY
2024-09-30 12:20:00
ADX
10 Mins
BUY
2024-09-30 12:20:00
EMA 5
5 Mins
BUY
Apps
Top Articles
1
南洋 - 凭单专栏/温世麟
2
Stock Pick Contest Year 2024
3
Indexstockpedia
Malaysia Property Market Outlook and Top Small Cap Picks Edition
4
save malaysia!
5
6
7
8
save malaysia!
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
RamsyNa
That one I agree with you, ameeya13. QR will surely show improvement in the next month
2 months ago